A deep-learning model combining radiomics and clinicopathologic data with breast DCE-MRI improves prediction of complete pathological response after chemotherapy.
Key Details
- 1Study led by Chaowei Wu, PhD, at Cedars-Sinai Medical Center.
- 2Model integrates clinicopathologic data, shape radiomics, and retrospective pharmacokinetic quantification radiomics.
- 3Included MRI data from 1,073 breast cancer patients (2002–2016).
- 4Model achieved higher AUCs (up to 0.82 on external datasets) vs. conventional methods.
- 5Reported accuracy 69%, sensitivity 95%, specificity 59%.
- 6Early pCR prediction aids personalized treatment planning.
Why It Matters
Improved prediction of chemotherapy response using AI-driven analysis of DCE-MRI could enable more personalized and effective treatment strategies in breast cancer, potentially improving outcomes. The results show better accuracy and generalizability than existing methods across multiple datasets.
Source
AuntMinnie
Related News
•Radiology Business
AMA Survey: Physicians Double AI Use, Wary About Patient-Directed Radiology AI
The share of U.S. doctors using AI in practice has doubled, yet many are hesitant about patients using AI for interpreting radiology results.
•AuntMinnie
Deep Learning Model Enhances MRI Detection of Brain Metastases
A deep learning model significantly improves speed and accuracy of brain metastasis detection on MRI scans.
•AuntMinnie
Google AI Studio's Performance in Lung Cancer Detection on CT Evaluated
Google AI Studio demonstrates moderate accuracy in identifying lung malignancy on CT, but requires further refinement before clinical use.